Laron Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
We studied 22 patients with LS from Ecuador, Israel (of Moroccan origin), Brazil, Chile, and the United States (of Mexican origin) who were homozygous for the E180splice mutation and compared them to control individuals for markers surrounding the GHR, intragenic polymorphisms, and Y-chromosome STR.
|
24664892 |
2014 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
|
14678285 |
2004 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation.
|
10870033 |
2000 |
Laron Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
Lessons from the genetics of laron syndrome.
|
18406284 |
1998 |
Laron Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
|
9467570 |
1998 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor.
|
9851797 |
1998 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue.
|
9661642 |
1998 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Abnormalities in the GHR produce an autosomal recessive form of GH resistance, the Laron syndrome, characterized by growth failure and the clinical appearance of severe GH deficiency despite elevated circulating GH levels.
|
9024232 |
1997 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
To test this hypothesis directly, we investigated patients displaying the classic features of Laron syndrome (familial GH resistance characterized by severe dwarfism and metabolic dysfunction), except for the presence of normal binding activity of the plasma GH-binding protein, a molecule that derives from the exoplasmic-coding domain of the GHR gene.
|
8137822 |
1994 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome.
|
8504296 |
1993 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
|
8450064 |
1993 |
Laron Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
We conclude that Laron dwarfism is due to abnormalities in the gene for GH receptor, which may differ from family to family.
|
2779634 |
1989 |
Laron Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
|
|
|
Laron Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Laron Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Laron Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
|
7565946 |
1995 |
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|